Protective effect of Bosutinib with caspase inhibitors on human K562 cells.

Saudi J Biol Sci · 2022 · PMC9072916 · PMID 35531147

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

There was a highly significant decrease of cells when treated with bosutinib alone and in combination with Boc-D-FMK in both S phase and G2/M phase.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.